Citation Impact
Citing Papers
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
2002 StandoutScienceNobel
Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma
2008
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Chromatin in pluripotent embryonic stem cells and differentiation
2006
The complexities of skeletal biology
2003 StandoutNature
Global Transcription in Pluripotent Embryonic Stem Cells
2008
B‐cell homeostasis: digital survival or analog growth?
2004
C-reactive Protein
2004 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Shared Principles in NF-κB Signaling
2008 Standout
Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter
2003
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
The Rel Protein DIF Mediates the Antifungal but Not the Antibacterial Host Defense in Drosophila
2000 StandoutNobel
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?
2011 StandoutNobel
The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation
1998
Missing Pieces in the NF-κB Puzzle
2002 Standout
A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells
2007 Standout
Disruption of Fnip1 Reveals a Metabolic Checkpoint Controlling B Lymphocyte Development
2012 StandoutNobel
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma
2009
Failure of Lymphopoiesis after Adoptive Transfer of NF-κB–Deficient Fetal Liver Cells
1997 Nobel
Nuclear factor-?B: its role in health and disease
2004
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
2000 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
2016 StandoutNobel
NF-κB regulation in the immune system
2002 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Pioneer factors: directing transcriptional regulators within the chromatin environment
2011
Requirement for NF-κB in osteoclast and B-cell development
1997
Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA
2004 StandoutNobel
Signaling to NF-κB
2004 Standout
Dissection of the NF-κB signalling cascade in transgenic and knockout mice
2006
NF-κB: a key role in inflammatory diseases
2001 Standout
Chromosomal translocations in cancer
2008
Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain
2000 Standout
The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression
2000
Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models
2006
CLOCK:BMAL1 is a pioneer-like transcription factor
2014 StandoutNobel
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Acute Lymphoblastic Leukemia
2004
The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response
2003
The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1
2004
Toll-Like Receptors
2003 Standout
A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα
2010 StandoutNobel
Xenopusoocytes reactivate muscle gene transcription in transplanted somatic nuclei independently of myogenic factors
2009 StandoutNobel
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
2002 Standout
Bendamustine: Rebirth of an Old Drug
2009
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Constitutive Activation of Toll-Mediated Antifungal Defense in Serpin-Deficient Drosophila
1999 StandoutScienceNobel
Bone Resorption by Osteoclasts
2000 StandoutScience
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
IκB Kinase Signaling Is Essential for Maintenance of Mature B Cells
2002
Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma
2005
Mechanisms Underlying Ubiquitination
2001 Standout
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
2006 StandoutNobel
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
2012 StandoutNobel
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
Activation of Src kinase Lyn by the Kaposi sarcoma–associated herpesvirus K1 protein: implications for lymphomagenesis
2005
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
1998 Standout
Molecular Genetics of Acute Lymphoblastic Leukemia
2005
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD
2014
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
Structural Motifs Involved in Ubiquitin-Mediated Processing of the NF-κB Precursor p105: Roles of the Glycine-Rich Region and a Downstream Ubiquitination Domain
1999 StandoutNobel
Innate Immune Recognition
2002 Standout
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
2000 Standout
Constitutive Nuclear Translocation of NF-κB in B Cells in the Absence of IκB Degradation
1999
Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB
1997
Iκb Kinase α Is Essential for Mature B Cell Development and Function
2001
Eukaryotic transcriptional control
1999 StandoutNobel
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation.
1999
Works of Heather Bendall being referenced
In vitro and ex vivo activity of SDX-105 (bendamustine) in drug-resistant lymphoma cells
2004
Induction of growth arrest and apoptosis by MNNG is associated with up-regulation of Cdk inhibitor p21 and down-regulation of cyclooxygenase-2 expression
2004
The role of E2A-PBX1 in leukemogenesis
2001
An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets
1999
Corepression of RelA and c-Rel Inhibits Immunoglobulin κ Gene Transcription and Rearrangement in Precursor B Lymphocytes
1996
Transcription Factor NF-κB Regulates Inducible Oct-2 Gene Expression in Precursor B Lymphocytes
1997
Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents
2008
The High-Mobility-Group Box Protein SSRP1/T160 Is Essential for Cell Viability in Day 3.5 Mouse Embryos
2003